PA's Health Dept. Releases Applicants' Details for State's Medical Cannabis Business Licenses – Cannabis Business Times
More information regarding Pennsylvania’s medical marijuana program was released by the state Secretary of Health Dr. Karen Murphy last week, as the Health Department released the names and location of companies that have applied for the 39 medical cannabis business licenses potentially available within the state.
Of the more than 500 packages the state received, 258 have been logged and are currently under review. One hundred and thirty-two of those were for cultivation licenses. The applications were categorized by location, and the Southeast region (comprising Philadelphia and its suburbs) had the highest concentration of grower applications with nearly a quarter of potential growers having applied for licenses in the area (31 license applications). The Northcentral region–home to three state and one national forest—received the least amount of applications with only 17.
“This has been a tremendous undertaking by a team working day and night to ensure that we have a safe and effective way to get medication to patients,” Secretary Murphy said during a briefing April 26. “As we continue to review permit applications and work on our temporary regulations based on feedback from the community, we move closer and closer to getting this desperately needed medicine into the hands of those who will benefit most from it.”
Cultivation applications came from varied sources: Some are born-and-bred Pennsylvania companies with interesting site locations, such as Bunker Botanicals LLC. If selected, Bunker Botanicals would retrofit a Cold War-era bunker in the Southeast region into a medical cannabis cultivation facility.
Other applicants are well-established cannabis companies in other legal markets trying to expand their businesses into what is anticipated to be a lucrative Pennsylvania market. (Projections by The Arcview Group estimate Pennsylvania will represent 9.2 percent of the country’s $22 billion value by 2020.)
One such applicant is Sanctuary Medicinals, which operates